NIRAMAI: A Revolutionary Breast Cancer Screening Solution Powered by AI | Analytics Insight
NIRAMAI Health Analytix is a deep-tech startup to detect early-stage breast cancer in a completely privacy-aware manner. Dr. Geetha Manjunath and Nidhi Mathur shares how the company has developed a novel software to detect breast cancer at a much earlier stage than traditional methods or self-examination.
- NIRAMAI Health Analytix is a health technology startup developing a novel solution to detect early-stage breast cancer in a completely privacy-aware manner.
- The company’s offerings include a cancer diagnosis solution to Hospitals and Diagnostic centers, as well as a low-cost triaging solution to improve rural healthcare through Government and Non-Profit Organizations.
- The core of Niramai software consists of novel computer algorithms based on artificial intelligence and machine learning over thermal images.
- • Age-agnostic: Breast cancer incidences among young women are on a rise and traditional methods remain ill-suited for preventive screening for young women.
- • Accurate: Niramai test has shown good accuracy of detecting breast abnormality in women of all age groups.